RENOVORX, INC. Increase (Decrease) in Accrued Liabilities
RENOVORX, INC. (RNXT) reported Increase (Decrease) in Accrued Liabilities of -$228.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-13
- RENOVORX, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $163.00K, a 79.12% increase year-over-year.
- RENOVORX, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$391.00K.
- RENOVORX, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $121.00K, a 26.22% decline year-over-year.
- RENOVORX, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $103.00K, a 51.64% decline year-over-year.
- RENOVORX, INC. increase (decrease) in accrued liabilities for fiscal 2025 was -$265.00K, a 141.67% decline from fiscal 2024.
- RENOVORX, INC. increase (decrease) in accrued liabilities for fiscal 2024 was $636.00K, a 1282.61% increase from fiscal 2023.
- RENOVORX, INC. increase (decrease) in accrued liabilities for fiscal 2023 was $46.00K, a 70.32% decline from fiscal 2022.
- RENOVORX, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $155.00K, a 54.68% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$228.00K 10-Q · filed 2026-08-13 | -$107.00K derived: sum of 3 quarters · filed 2026-08-13 | -$4.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$391.00K 10-Q · filed 2026-05-14 | -$270.00K derived: sum of 2 quarters · filed 2026-05-14 | -$167.00K derived: sum of 3 quarters · filed 2026-05-14 | -$76.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $224.00K derived: sum of 2 quarters · filed 2026-03-30 | $315.00K derived: sum of 3 quarters · filed 2026-08-13 | -$265.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $194.00K derived: sum of 2 quarters · filed 2026-08-13 | -$386.00K 10-Q · filed 2025-11-13 | -$222.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$489.00K 10-Q · filed 2026-08-13 | -$325.00K derived: sum of 3 quarters · filed 2026-08-13 | -$112.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$580.00K 10-Q · filed 2026-05-14 | -$416.00K derived: sum of 2 quarters · filed 2026-05-14 | -$203.00K derived: sum of 3 quarters · filed 2026-05-14 | -$67.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $377.00K derived: sum of 2 quarters · filed 2026-03-30 | $513.00K derived: sum of 3 quarters · filed 2026-03-30 | $636.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $213.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $349.00K derived: sum of 2 quarters · filed 2025-11-13 | $472.00K 10-Q · filed 2025-11-13 | -$169.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $259.00K 10-Q · filed 2025-08-14 | -$382.00K derived: sum of 3 quarters · filed 2025-08-14 | $46.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $123.00K 10-Q · filed 2025-05-15 | -$518.00K derived: sum of 2 quarters · filed 2025-05-15 | -$90.00K derived: sum of 3 quarters · filed 2025-05-15 | $260.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$641.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | -$213.00K derived: sum of 2 quarters · filed 2025-04-01 | $137.00K derived: sum of 3 quarters · filed 2025-04-01 | $46.00K 10-K · filed 2025-04-01 |
| 2023-09-30 | $428.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $778.00K derived: sum of 2 quarters · filed 2024-11-13 | $687.00K 10-Q · filed 2024-11-13 | $691.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $350.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $259.00K 10-Q · filed 2024-08-13 | $263.00K derived: sum of 3 quarters · filed 2024-08-13 | $177.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$91.00K 10-Q · filed 2024-05-10 | -$87.00K derived: sum of 2 quarters · filed 2024-05-10 | -$173.00K derived: sum of 3 quarters · filed 2024-05-10 | -$200.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$82.00K derived: sum of 2 quarters · filed 2024-04-01 | -$109.00K derived: sum of 3 quarters · filed 2024-04-01 | $155.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$113.00K derived: sum of 2 quarters · filed 2023-11-13 | $151.00K 10-Q · filed 2023-11-13 | $72.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | $237.00K 10-Q · filed 2023-08-16 | $158.00K derived: sum of 3 quarters · filed 2023-08-16 | $453.00K derived: sum of 4 quarters · filed 2023-08-16 |
| 2022-03-31 | $264.00K 10-Q · filed 2023-05-12 | $185.00K derived: sum of 2 quarters · filed 2023-05-12 | $480.00K derived: sum of 3 quarters · filed 2023-05-12 | $504.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $216.00K derived: sum of 2 quarters · filed 2023-03-31 | $240.00K derived: sum of 3 quarters · filed 2023-03-31 | $342.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $295.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $319.00K derived: sum of 2 quarters · filed 2022-11-14 | $421.00K 10-Q · filed 2022-11-14 | $143.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $126.00K 10-Q · filed 2022-08-12 | -$152.00K derived: sum of 3 quarters · filed 2022-08-12 | |
| 2021-03-31 | $102.00K 10-Q · filed 2022-05-13 | -$176.00K derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2020-12-31 | -$278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$21.00K 10-K · filed 2022-03-30 | ||
| 2020-09-30 | $257.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |